Michael Monko Named Vice President Sales, Serologicals Corporation Research Products Group

Serologicals Corporation (NASDAQ: SERO) announced today
that Michael Monko has joined the Company as Vice President, Sales for
the Research Products Segment, consisting of Chemicon International,
Inc. and the Upstate Group, Inc. Mr. Monko will report directly to
Jeffrey D. Linton, President and will be a member of Research Segment
Executive Operating Committee. In his new role, Mr. Monko will direct
all sales activities worldwide for the Company's research products and
drug discovery markets bringing his many years of expertise in these
sectors to our customers and sales team.
   "We are delighted that Mike has joined the Company at this
important time as we accelerate our growth and expand our market
leadership positions," said Mr. Linton. "Mike has significant
experience in our industry and possesses exceptional leadership
skills. His extensive knowledge and background will be beneficial in
further expanding our customer development activities. In addition, we
are looking forward to him leading our sales teams as they continue to
create expanded growth opportunities and through providing focus on
the professional development of our research products sales
organization."
   Prior to joining the Company, Mr. Monko worked nearly 20 years for
Invitrogen Corporation (NASDAQ: IVGN) in several sales leadership
positions. Most recently, he was the Senior Director, Sales Force
Effectiveness. Prior to that, he was the Senior Director of Sales,
directing the academic and industrial sales organization responsible
for developing and implementing strategic sales plans resulting in
substantial sales growth for that organization.
   Mr. Monko received an MBA degree from Babson College in Wellesley,
MA and a Bachelor of Science degree in Biochemistry from the
University of New Hampshire. Mr. Monko will be based in Serologicals'
Temecula, California office.
   Serologicals Corporation (NASDAQ: SERO), headquartered in Atlanta,
GA, is a global leader in developing and commercializing consumable
biological products, enabling technologies and services in support of
biological research, drug discovery, and the bioprocessing of
life-enhancing products. Our customers include researchers at major
life science companies and leading research institutions involved in
key disciplines, such as neurology, oncology, hematology, immunology,
cardiology, proteomics, infectious diseases, cell signaling and stem
cell research. In addition, Serologicals is the world's leading
provider of monoclonal antibodies for the blood typing industry.
Serologicals employs a total of more than 1,000 people worldwide in
three Serologicals' companies: Chemicon International, headquartered
in Temecula, CA, Upstate Group, LLC, headquartered in Charlottesville,
VA and Celliance Corporation, headquartered in Atlanta, GA.
   For more information, please visit our website:
www.serologicals.com.
   Serologicals is a registered trademark of Serologicals Investment
Company.